News | News By Subject | News by Disease News By Date | Search News

Breast Cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Bristol-Myers Squibb (BMY), Clovis Oncology (CLVS) Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III     8/1/2017
Bay Area Nektar (NKTR)' Comeback is Stalled as the EMA Rejects Breast Cancer Drug     7/21/2017
Puma Biotech (PBYI) Surges After the FDA Officially Approves Breast Cancer Drug     7/19/2017
Genentech (RHHBY)’s Perjeta-Based Adjuvant Breast Cancer Care Shows Minor Improvement, Puma Biotech (PBYI) Shares Jump     6/6/2017
Puma Biotech (PBYI) Defies Odds, Wins FDA Backing for Breast Cancer Drug     5/25/2017
Puma Biotech (PBYI) Surges on the FDA's Positive Breast Cancer Review     5/23/2017
Pfizer (PFE) Giving Out Cutting-Edge Cancer Drug for Free While Awaiting NHS Decision     5/5/2017
Genentech (RHHBY) Quietly Shelves Phase II Cancer Contender     4/28/2017
Former Pfizer (PFE) Cancer Scientist Gets All 5 Papers Retracted     4/24/2017
AbbVie (ABBV)'s PARP Inhibitor Fails to Deliver in Two Late-Stage Studies     4/20/2017
FDA's Shorten Review Time is a Bad Sign for Puma Biotech (PBYI)'s Controversial Cancer Drug     4/20/2017
Investors Squeal With Delight as Eli Lilly (LLY)'s Breast Cancer Combo Succeeds in Phase III, Faces Tough Competition from Pfizer (PFE) and Novartis AG (NVS)     3/21/2017
Genentech (RHHBY) New Breast Cancer Cocktail Cuts Deaths in Phase III Study, Roche (RHHBY) Stock Soars     3/3/2017
AstraZeneca PLC (AZN) Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial     2/20/2017
Roche (RHHBY) Faces Off With Itself for $9 Billion Breast Cancer Drug Business     2/15/2017

News from Around the Web
Blood-Based Breast Cancer Detection Test May Help Avoid Biopsy, Clinical Breast Cancer Reveals     5/26/2017
There’s A Therapeutic Curveball Heading For The FDA     5/25/2017
A Drink A Day Tied To Higher Breast Cancer Risk, American Institute for Cancer Research Report Says     5/24/2017
Trump's New HHS Appointee Yoest Thinks Abortion Raises Breast Cancer Risk, But Where's The Evidence?     5/2/2017
Researchers Create New Diagnostic Tool For Detecting Breast Cancer, Simon Fraser University Study Reveals     4/7/2017
Sought-After Tesaro (TSRO) Sees A $5 Billion Opportunity For Its Cancer Drug     2/17/2017
Scalp Cooling Device May Help Reduce Hair Loss For Women With Breast Cancer On Chemotherapy, JAMA Reveals     2/15/2017
Biggest Breast Cancer Breakthrough: Map Links Cell Shape And Genes To Disease Outcomes, Institute of Cancer Research in London Study     2/6/2017
Were Women Foolish To Follow Angelina Jolie Into BRCA Cancer Gene Testing?     1/5/2017
Breast Cancer Cells Do Not Like It Spicy, Ruhr-University Study     12/22/2016
How 3 Huge Discoveries in 2016 are Moving Us Closer to a Breast Cancer Cure     10/24/2016
Puma Biotech (PBYI)'s $150 Million Stock Offering May Signal to Investors That Its Breast Cancer Drug is in Trouble     10/20/2016
Mammograms More Likely To Cause Unneeded Treatment Than To Save Lives, Published In BMJ     10/13/2016
Newly Developed: Non-Invasive, Safe Tester For Breast Cancer Diagnosis, Polish Biotech Braster Reveals     10/7/2016
Implant Improves Breast Cancer Survival, University of Michigan Study     9/30/2016

Press Releases
Detection Of Circulating Tumor Cells In Breast Cancer Patients Using The GILUPI CellCollector     8/9/2017
Avelas Biosciences Doses First Patient In Phase II Study Of AVB-620 In Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery     8/4/2017
Amgen (AMGN) And Allergan (AGN) Submit Biosimilar Biologics License Application For ABP 980 To FDA     7/31/2017
Generex Biotechnology Corporation (GNBT) Announces Collaboration With Merck & Co. (MRK) To Evaluate KEYTRUDA (Pembrolizumab) In Combination With AE37 In Patients With Triple-Negative Breast Cancer     7/31/2017
Verastem (VSTM) Publishes Scientific Data Highlighting Potential Role Of FAK Inhibition In Pancreatic And Breast Cancer     7/25/2017
Xbrane Biopharma: Spherotide Granted Market Authorization In Iran     7/24/2017
Seattle Genetics (SGEN) Announces Clinical Collaboration To Expand The Therapeutic Evaluation Of SGN-LIV1A In Triple Negative Breast Cancer     7/24/2017
BioLogics Release: NERLYNX (Neratinib) Tablets Approved For HER2+ Breast Cancer In The Extended Adjuvant Setting     7/21/2017
BriaCell Provides Clinical Update On Its Ongoing Phase I/IIa Clinical Study Of BriaVax In Advanced Breast Cancer     7/19/2017
MetaStat Release: Study Demonstrates Paclitaxel Treatment Promotes Breast Cancer Dissemination And Metastasis In A Mena-Dependent Manner     7/19/2017
Avant Diagnostics Highlights Published Clinical Utility Data For Theralink mTOR Pathway Activation Data Predicting Tamoxifen And Other Endocrine Treatment Response In Estrogen Receptor Positive (ER+) Breast Cancer     7/18/2017
FDA Oncologic Drugs Advisory Committee Unanimously Recommends Approval Of Mylan (MYL) And BioCon (BIOCON.NS)'s Proposed Biosimilar Trastuzumab     7/14/2017
Cohera Medical Release: Tissuglu Surgical Adhesive Facilitates Drain-Free Mastectomy     7/12/2017
FDA Grants Priority Review For Eli Lilly (LLY)'s Abemaciclib For The Treatment Of Advanced Breast Cancer     7/10/2017
Biocartis And A*STAR’s ETPL Initiate Development Of Breast Cancer Assay To Guide Therapy Selection     7/10/2017

//-->